CISPLATIN-BASED CHEMOTHERAPY FOR HIGH RISK GESTATINAL TROPHOBLASTIC NEOPLASIA: EP OR EMACP

被引：0
|
作者：
Gaykema, S. [1 ]
Gietema, J. A. [1 ]
Arts, H. J. G. [1 ]
Lutgers, H. L. [1 ]
Reyners, A. K. L. [1 ]
机构：
[1] Univ Med Ctr Groningen, NL-9713 AV Groningen, Netherlands
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2013年 / 23卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Comparing cisplatin-based combination chemotherapy with EMA/CO chemotherapy for the treatment of high risk gestational trophoblastic neoplasia
    Lybol, C.
    Thomas, C. M. G.
    Blanken, E. A.
    Sweep, F. C. G. J.
    Verheijen, R. H.
    Westermann, A. M.
    Boere, I. A.
    Reyners, A. K. L.
    Massuger, L. F. A. G.
    van Hoesel, R. Q. G. C. M.
    Ottevanger, P. B.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 (04) : 860 - 867
  • [2] Cisplatin-based chemotherapy increases VTE risk
    Reactions Weekly, 2012, 1429 (1) : 3 - 3
  • [3] Secondary chemotherapy for high-risk gestational trophoblastic neoplasia
    Lurain, JR
    Nejad, B
    GYNECOLOGIC ONCOLOGY, 2005, 97 (02) : 618 - 623
  • [4] High risk vascular fingerprint in patients treated with cisplatin-based chemotherapy for testicular cancer
    Lubberts, Sjoukje
    Boer, Hink
    Altena, Renske
    Meijer, Coby
    van Roon, Arie M.
    Zwart, Nynke
    Oosting, Sjoukje
    Kamphuisen, Pieter W.
    Nuver, Janine
    Smit, Andries J.
    Mulder, Andre B.
    Lefrandt, Joop D.
    Gietema, Jourik A.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [5] Prevalence and risk factors for ototoxicity after cisplatin-based chemotherapy
    Sanchez, Victoria A. A.
    Dinh Jr, Paul C. C.
    Rooker, Jennessa
    Monahan, Patrick O. O.
    Althouse, Sandra K. K.
    Fung, Chunkit
    Sesso, Howard D. D.
    Einhorn, Lawrence H. H.
    Dolan, M. Eileen
    Frisina, Robert D. D.
    Travis, Lois B. B.
    JOURNAL OF CANCER SURVIVORSHIP, 2023, 17 (01) : 27 - 39
  • [6] Prevalence and risk factors for ototoxicity after cisplatin-based chemotherapy
    Victoria A. Sanchez
    Paul C. Dinh
    Jennessa Rooker
    Patrick O. Monahan
    Sandra K. Althouse
    Chunkit Fung
    Howard D. Sesso
    Lawrence H. Einhorn
    M. Eileen Dolan
    Robert D. Frisina
    Lois B. Travis
    Journal of Cancer Survivorship, 2023, 17 : 27 - 39
  • [7] Unraveling resistance to cisplatin-based chemotherapy
    Laffman-Johnson, Elise
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 86 (04) : 348 - 348
  • [8] INTRATESTICULAR EFFECTS OF CISPLATIN-BASED CHEMOTHERAPY
    DIECKMANN, KP
    LOY, V
    EUROPEAN UROLOGY, 1995, 28 (01) : 25 - 30
  • [9] Results of chemotherapy with etoposide, methotrexate, cyclophosphamide, actinomycine D and cisplatin (EMCAP) chemotherapy for high risk gestational trophoblastic neoplasia, a retrospective study by the Dutch Working Party on Trophoblastic Tumors
    Ottevanger, P. B.
    Blanken, E. A.
    Groenewoud, J. M. M.
    van Hoesell, Q.
    Westermann, A. M.
    van Drierl, W. J.
    van de Burg, M. E. L.
    Nooij, M. A.
    Verheijen, R. H. M.
    EJC SUPPLEMENTS, 2009, 7 (02): : 466 - 466
  • [10] Choriocarcinoma of the gallbladderTreated with cisplatin-based chemotherapy
    Jen C. Wang
    Santos Angeles
    Peter Chak
    Ann B. Platt
    Nagabhushana Nimmagadda
    Medical Oncology, 2001, 18 : 165 - 169
12345